ADIL - Retrace To Support - Good Entry?ADIAL saw an increase in volume and runup to 3.30 after which we saw a retrace to the 2.18 support level that held nicely. The upward trendline has been holding consistently on the daily and weekly charts. I am looking for a bullish engulfing or gap up opening with retrace to higher low to confirm t
Key stats
Market capitalization
10.044MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.6887USD
About Adial Pharmaceuticals, Inc
ISIN
US00688A1060
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
adialpharma.com
CEO
Cary J. Claiborne
Headquarters
Charlottesville
Employees
18
Founded
2010
Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.
$ADIL is gonna to fall todayPupm&Dump trading strategy idea.
$ADIL is rising without clear preconditions today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,10;
stop-loss — $2,35.
take-profit — $1,
ADIL: Next Target is $1.75 --> Bullish SupportFirst off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said, I am keeping a close watch on ADIL. It seems to have continued bullish support and looks like it can continue on a positive run all the until way next week for
Insider confidence in Adial Pharmaceuticals bodes wellAs Adial Pharmaceuticals advances its Phase 3 clinical trial of AD04 for the treatment of alcohol use, insiders are showing confidence in the company. Today they appointed Mark Howard Peikin as chief strategy officer, and he took the position without a salary. Instead, he accepted a stock option as
ADIL10:09 AM EDT, 09/11/2019 (MT Newswires) -- Adial Pharmaceuticals (ADIL) said Wednesday that it has successfully retested a previously manufactured supply of clinical trial packaged tablets of the investigational drug AD04 for the treatment of alcohol use disorder.
The company said tests showed that
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0